Physician
Neurology
Dr. Alan M. Rapoport, MD
|
|
Give Review
Dr. Alan M. Rapoport works in the field of Neurology. He went to Mount Sinai School of Medicine. Alan Rapoport is also published. He has 102 publications published. The lastest publication: "Clinico-tremorgraphic features of neuroleptic-induced tremor.' Alan Rapoport accepts all Medicare patients.
Publications
- Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controll...
- Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study.
- Therapeutic antibodies against CGRP or its receptor.
- New treatments for Headache.
- The Vasodilatory Activity of CGRP: A Response.
- Erratum to: Why Does Vomiting Stop a Migraine Attack?
- Intranasal zolmitriptan for the treatment of acute migraine.
- Why does vomiting stop a migraine attack?
- The Pipeline in Headache Therapy.
- Calcitonin Gene-Related Peptide (CGRP) and Migraine Current Understanding and State of Development.
- Acute treatment of migraine: established and emerging therapies.
- Obesity and Chronic Daily Headache.
- Acute and preventive pharmacologic treatment of cluster Headache.
- Migraine and obesity: epidemiology, mechanisms, and implications.
- Chronic daily Headache in adolescents: an 8-year follow-up study.
- Obesity and migraine: the effect of age, gender and adipose tissue distribution.
- Zolmitriptan nasal spray in the acute treatment of cluster Headache: a meta-analysis of two studies.
- Ten years of rizatriptan: from development to clinical science and future directions.
- Advances in the pharmacologic treatment of tension-type Headache.
- The impact of topiramate on health-related quality of life indicators in chronic migraine.
- High-altitude Headache.
- Medications associated with probable medication overuse Headache reported in a tertiary care Headache center over a 15-year period.
- Naratriptan in the preventive treatment of refractory transformed migraine: a prospective pilot study.
- Tinnitus in migraine: an allodynic symptom secondary to abnormal cortical functioning?
- Principles of migraine diagnosis and management. A synthesis.
- A patient-based approach to migraine clinical trials data. An overview.
- The classification of chronic daily Headache in adolescents--a comparison between the second edition of the international classification of Headache disorders and alte...
- Assessment of adverse events associated with triptans--methods of assessment influence the results.
- Botulinum neurotoxin type A in the preventive treatment of refractory Headache: a review of 100 consecutive cases.
- Chronic daily Headache: correlation between the 2004 and the 1988 International Headache Society diagnostic criteria.
- Patterns of use of triptans and reasons for switching them in a tertiary care migraine population.
- Prophylactic migraine therapy: emerging treatment options.
- The effect of weather on Headache.
- Analgesic use: a predictor of chronic pain in medication overuse Headache: the Head-HUNT study.
- Burden of migraine in Brazil: estimate of cost of migraine to the public health system and an analytical study of the cost-effectiveness of a stratified model of care.
- Naratriptan in the preventive treatment of refractory chronic migraine: a review of 27 cases.
- Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraine.
- The clinical spectrum of migraine.
- Chronic daily Headache: identification of factors associated with induction and transformation.
- Mechanisms of action of the 5-HT1B/1D receptor agonists.
- Ethical considerations in cluster Headache research.
- [Clinical and epidemiological characteristics of squamous cell carcinoma of the oral cavity in women].
- Slit-like ventricles.
- Combined resting-postural tremor of lower limbs: another essential tremor variant.
- Unilateral akathisia.
- Migraine: the evolution of our knowledge.
- Laboral outcome after acute unilateral vestibulopathy.
- Perioperative frozen section examination in parotid gland tumors.
- Increased cerebrospinal fluid glutamine levels in depressed patients.
- Evaluation of lymph node reactivity in differentiated thyroid carcinoma.
- Contrasting effect of hemodialysis and peritoneal dialysis on the inhibition of in vitro calcification by uremic serum.
- Home peritoneal dialysis: 3 years'' experience in Toronto.
- Correlates of survival after initiation of chemotherapy in 142 cases of Hodgkin''s disease.
- Prognostic factors and relative risk in hypopharyngeal cancer--related parameters concerning stage, therapeutics and evolution.
- Akathisia and pseudoakathisia: clinical observations and accelerometric recordings.
- Pericarditis in patients undergoing long-term hemodialysis and peritoneal dialysis. Incidence, complications and management.
- Cerebrospinal cytokine levels in patients with acute depression.
- High serum and cerebrospinal fluid Ca/Mg ratio in recently hospitalized acutely depressed patients.
- Clinico-tremorgraphic features of neuroleptic-induced tremor.
- Continuous infusion cyclosporine and nifedipine to day +100 with short methotrexate and steroids as GVHD prophylaxis in unrelated donor transplants.
- Proliferating cell nuclear antigen expression in mucoepidermoid carcinoma of salivary glands.
- A standardized test of renal concentrating capacity in adults with some results in essential hypertension.
- Metabolic balance studies in patients with Paget''s disease receiving salmon calcitonin over long periods.
- CSF inositol does not predict antidepressant response to inositol. Short communication.
- Characteristics of migraine visual aura in Southern Brazil and Northern USA.
- Favorable outcome of early treatment of new onset child and adolescent migraine-implications for disease modification.
- Innovative delivery systems for migraine: the clinical utility of a transdermal patch for the acute treatment of migraine.
- New drug delivery options for migraine.
- New acute treatments for Headache.
- Triptans for the management of migraine.
- Role of antiepileptic drugs as preventive agents for migraine.
- Clinical pharmacology of the serotonin receptor agonist, zolmitriptan.
- Medication overuse Headache: awareness, detection and treatment.
- Acute and prophylactic treatments for migraine: present and future.
- Acute treatment of Headache.
- Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
- Role of melatonin in the pathophysiology of migraine: implications for treatment.
- The Global Campaign (GC) to Reduce the Burden of Headache Worldwide. The International Team for Specialist Education (ITSE).
- Acute treatment of migraine with zolmitriptan 5 mg orally disintegrating tablet.
- Sumatriptan: a decade of use and experience in the treatment of migraine.
- Zolmitriptan (Zomig).
- Intranasal medications for the treatment of migraine and cluster Headache.
- New migraine preventive options: an update with pathophysiological considerations.
- New developments in migraine prophylaxis.
- The triptan formulations : how to match patients and products.
- Hemicrania continua: a report of ten new cases.
- Chronic daily Headache in a tertiary care population: correlation between the International Headache Society diagnostic criteria and proposed revisions of criteria for...
- Hemicrania continua: comparison between two different classification systems.
- Cluster Headache as a manifestation of intracranial inflammatory myofibroblastic tumour: a case report with pathophysiological considerations.
- Hemicrania continua: clinical and nosographic update.
- Transformed migraine and medication overuse in a tertiary Headache centre--clinical characteristics and treatment outcomes.
- Preventive migraine therapy: what is new.
- Botulinum toxin A for the treatment of greater occipital neuralgia and trigeminal neuralgia: a case report with pathophysiological considerations.
- Chronic migraine is an earlier stage of transformed migraine in adults.
- Migraine days decline with duration of illness in adolescents with transformed migraine.
- Field testing alternative criteria for chronic migraine.
- Satisfaction with current migraine therapy: experience from 3 centers in US and Sweden.
- Comparative study of a combination of isometheptene mucate, dichloralphenazone with acetaminophen and sumatriptan succinate in the treatment of migraine.
- Characteristics of migraine visual aura.
- Optimizing the dose of zolmitriptan (Zomig, 311C90) for the acute treatment of migraine. A multicenter, double-blind, placebo-controlled, dose range-finding study. The...
- Indomethacin Responsive Headaches: Exhaustive Systematic Review With Pooled Analysis and Critical Appraisal of 81 Published Clinical Studies.
Schools
Suny Downstate Medical Center
Maimonides Med Center
Mt Sinai Hospital
National Institute Of Health
Conditions Treated
- Carpal Tunnel Syndrome
- Epilepsy
- Headache
- Insomnia
- View All
Doctors Specialties
- Neurology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- Blue Cross Blue Shield of California PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Education
-
Mount Sinai School of Medicine -
Maimonides Medical Center -
State University of New York Downstate Medical Center College of Medicine
Hospital
-
Ronald Reagan UCLA Medical Center
Drug Facts
| NPI NUMBER | 1922042480 | |
| NPPES Provider LastName | RAPOPORT | |
| NPPES Provider FirstName | ALAN | |
| NPPES Provider ZIPCode | 904042102 | |
| NPPES Provider State | CA | |
| Specialty Description | Neurology | |
| Total Claim Count | 39.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1922042480 |
| Last Name Of The Provider | RAPOPORT |
| First Name Of The Provider | ALAN |
| View All |
Similar Doctors
|
Dr. Sheldon E. Jordan, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hyman Gross, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David B. Kudrow, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edwin Amos, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Edward J. O'Connor, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dawn Eliashiv, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shamsha Velani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leo Treciokas, MD
This Doctor is OpenDoctor Recommended.
|